Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Long-Term Investments (2024 - 2025)

PAVmed (PAVM) has 2 years of Long-Term Investments data on record, last reported at $31.6 million in Q3 2025.

  • For Q3 2025, Long-Term Investments changed N/A year-over-year to $31.6 million; the TTM value through Sep 2025 reached $31.6 million, changed N/A, while the annual FY2024 figure was $25.6 million, N/A changed from the prior year.
  • Long-Term Investments reached $31.6 million in Q3 2025 per PAVM's latest filing, down from $36.0 million in the prior quarter.
  • Across five years, Long-Term Investments topped out at $46.6 million in Q1 2025 and bottomed at $25.6 million in Q4 2024.